John Ayres is Associate General Counsel with Genprex, Inc., a clinical stage gene therapy company focusing on therapies for patients with cancer and diabetes. John is a corporate, M&A and securities lawyer who was trained at Latham & Watkins. Prior to joining Genprex John worked for Aratana Therapeutics and Artio Medical.
